VALIDATE Annual Meeting 2023 - Posters

Along with keynote talks, research presentations by VALIDATE-funded projects, and time for networking, we aim to hold a Poster Session at the Annual Meeting, so that more VALIDATE members can publicise their research.

You can find a full list of presenters, and their titles and abstracts, below:

 

Dr Kiran Afshan

Quaid-i-Azam University, Islamabad, Pakistan

Ecological Niche Modeling and clinico-epidemiological distribution of cutaneous leishmaniasis among inhabitants of Khyber Pakhtunkhwa, Pakistan (abstract)

 

Professor Abdul Alim Al-Bari

University of Rajshahi, Bangladesh

Immune modulation of autophagy represents a promising strategy for host-directed therapy against mycobacteria (abstract)

 

Dr Luciana Balboa

Institute of Experimental Medicine (IMEX), CONICET-National Academy of Medicine, Argentina

Rewiring of Macrophage Metabolism By Lipid Mediators Derived From Omega-3 Fatty Acids: Its Impact on The Control Of Mycobacterium Tuberculosis Infection (abstract)

 

Dr Suraj Bhattarai

Global Institute for Interdisciplinary Studies, Nepal

Nepal: An urgent need to generate evidence through global collaboration (abstract)

 

Dr Federico Blanco

National Institute of Agricultural Technology (INTA), Argentina

Comparative transcriptomic profiles of bovine differentiated macrophages and autologous lymphocytes co-cultures infected with two M. bovis isolates of opposite virulence phenotypes reveals a differential upregulation of type I IFN pathway genes (abstract)
 

Dr Paul Brett

University of Nevada, Reno School of Medicine, USA

Development of Scalable Processes to Facilitate GMP‐Compliant Production of a Melioidosis Subunit Vaccine Candidate (abstract)

 

Dr Mary Burtnick

University of Nevada, Reno School of Medicine, USA

Optimization of Serological Assays for the Analysis of Antigen-Specific Antibody Responses in Melioidosis Patients (abstract)

 

Dr Naomi Daniels

University of Otago, New Zealand

Investigating the evasion of BCG-mediated trained innate immune responses by Beijing-Mtb (abstract)

 

Dr Somasish Ghosh Dastidar

Manipal Academy of Higher Education, India

Genomic and biochemical characterization of ‘novel’ Burkholderia pseudomallei clinical isolates from Melioidosis and Neuromelioidosis patients from Southern India and their virulome and phylogenomic profiling (abstract)

 

Ms Su-Mari Du Plessis

Stellenbosch University, South Africa

Biomimetic nanoparticle-based host-directed therapy for the eradication of Mycobacterium tuberculosis (abstract)

 

Professor Makram Essafi

Institut Pasteur de Tunis, Tunisia

Activation of the Host FOXO3 during BCG vaccination confers higher protection against Mycobacterium tuberculosis (abstract)

 

Dr Nidhi Gupta

University of Delhi South Campus, India

Adjuvants for vaccine: receptor ligand based molecular interaction to discover adjuvants for human toll like receptors (abstract)

 

Mrs Stephanie Harris

University of Oxford, UK 

Developing a Controlled Human Infection Model with Intradermal or Aerosol BCG as a Surrogate for M. tb Infection (abstract)

 

Dr Nancy J Hilda

ICMR - National Institute for Research in Tuberculosis, India

Impact Of Recent Covid-19 Infection on Neutrophil Extracellular Traps Formed During Tuberculosis (abstract)

 

Mr Jelalu Kemal Birmeka

Haramaya University, Ethiopia

Prevalence, Risk Factors and Public Health Importance of Bovine Tuberculosis in Eastern Ethiopia (abstract)

 

Professor Ian Jones

University of Reading, UK

The ESX-1 secretion-associated protein EspA may mediate liquid-liquid phase separation (abstract)

 

Dr Rajiv Kumar

Banaras Hindu University India, India

Distinct CD4 + T Cells Immunological Signature in Patients with Post Kala-Azar Dermal Leishmaniasis (abstract)

 

Ms Millicent Naa Koshie Lamptey

Kumasi Center for Collaborative Research in Tropical Medicine, Ghana

Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients (abstract)

 

Dr Alba Llibre

University of Birmingham, UK

Integration of comprehensive tuberculosis clinical data, functional ex vivo mycobacterial growth inhibition assays and mass cytometry data to understand the reciprocal impact of M.tb and Covid-1 (abstract)

 

Dr Suzie Madaki

Bayero University, Nigeria

An Assessment Of Percentage and Absolute Cd4 Lymphocytes Levels and Factors Influencing Their Levels in Tuberculosis Patients Receiving Treatment n Barau Dikko Teaching Hospital, Kaduna, Nigeria (abstract)

 

Ms Erin McMaster

Stellenbosch University, South Africa

Ferrocenyl-sulfonamide Derivatives as Anti-mycobacterial Agents (abstract)

 

Dr Zaynab Mousavian

Karolinska Institute, Sweden

Network-based analysis reveals a plasma protein signature associated with active Tuberculosis (abstract)

 

Professor Tufária Nazimo Ibrahimo Mussá

Faculty of Medicine, Eduardo Mondlane University, Mozambique

Diabetes Mellitus and cytokine profile in new Tuberculosis subjects with or without HIV in Maputo-south Mozambique (abstract)

 

Mr Mberkadji Salem Ngana

Medical Research Council The Gambia at London School of Hygiene and Tropical Medicine, The Gambia

Analysis of the impact of monocytes differentiation on Mycobacterium tuberculosis complex infection (abstract)

 

Ms Jacent Nassuuna

MRC/UVRI and LSHTM Uganda Research Unit, Uganda

Effect of Intensive Treatment For Schistosomiasis, and of The Rural-Urban Environment, on Vaccine-Specific Immune Responses in Ugandan Adolescents (abstract)

 

Mrs Naffie Top

MRC Unit the Gambia, Gambia

The role of macrophage differentiation on Mycobacterium tuberculosis complex lineages response to Tyrosine kinase inhibitors.  (abstract)

 

Mrs Charlotte Sarfas

UK Health Security Agency, UK

Characterisation of the infant immune system and the influence and immunogenicity of BCG vaccination in infant and adult rhesus macaques (abstract)

 

Dr Sadaf Sulman

University of the Punjab, Pakistan

Balance between Protection and Pathogenic Response to Aerosol Challenge with Mycobacterium tuberculosis (Mtb) in Mice Vaccinated with TriFu64, a Fusion Consisting of Three Mtb Antigens (abstract)

 

Ms Garima K Shekhawat

Central University of Rajasthan, India

Mycobacterium tuberculosis Protein Tyrosine Phosphatase B as Vaccine Candidate against Tuberculosis (abstract)

 

Dr Ludoviko Zirimenya

MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda

A randomised clinical trial investigating the effect of BCG revaccination on the response to unrelated vaccines in Ugandan adolescents (abstract)